RETROVIR (AZT) 10 MG
ZIDOVUDINE : 10 MG · DIN 01902644 · VIIV HEALTHCARE ULC
Health Canada status: MARKETED
What is RETROVIR (AZT)?
RETROVIR (AZT) 10 MG contains ZIDOVUDINE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 01902644, held by VIIV HEALTHCARE ULC, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 11-Feb-2011. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is RETROVIR (AZT) used for?
RETROVIR (AZT) (zidovudine syrup, and solution for infusion) is indicated for the treatment of HIV infection when antiretroviral therapy is warranted. RETROVIR (AZT) is also indicated for the prevention of maternal - fetal HIV transmission as part of a regimen that includes oral RETROVIR (AZT) beginning between 14 and 34 weeks of gestation, intravenous RETROVIR (AZT) during labour, and administration of RETROVIR (AZT) Syrup to the newborn after birth.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is RETROVIR (AZT) called?
The same molecule, ZIDOVUDINE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Retrovir | Latin | Australia, Bahrain, Morocco, South Africa, United Arab Emirates |
| Aspen Zidovudine | Latin | South Africa |
| AVIRO-Z | Latin | Morocco |
| Cipla Zidovudine Oral Solution | Latin | South Africa |
| Cipla-Zidovudine | Latin | South Africa |
| ZIDOVIR | Latin | Morocco |
| Adco-Zidovudine Syrup | Latin | South Africa |
| Adco-Zidovudine Tablets | Latin | South Africa |
| Aspen Zidovudine Syrup | Latin | South Africa |
| Cipla Duovir | Latin | South Africa |
| Colamziv | Latin | South Africa |
| Mivirdo | Latin | South Africa |
| Retrovir IV | Latin | South Africa |
| Triplavar | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 01902644 |
|---|---|
| Brand name | RETROVIR (AZT) |
| Generic / active ingredient | ZIDOVUDINE : 10 MG |
| Manufacturer | VIIV HEALTHCARE ULC |
| Strength | 10 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | J05AF01 ZIDOVUDINE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 11-Feb-2011 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 01902644 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1902644 |
| Brand name | RETROVIR (AZT) |
| Active ingredient / INN | ZIDOVUDINE : 10 MG |
| ATC code | J05AF01 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J05 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | VIIV HEALTHCARE ULC |
How is it stored and handled?
The diluted solution should be administered within 8 hours if stored at 25ºC (77ºF) or 24 hours if refrigerated at 2º to 8ºC
How is it supplied?
Syrup: Supplied in 240 mL bottles. Solution for Infusion: Supplied as 20 mL single-use amber vial. Box of 5 vials.
Which pack is which?
| Strength on the label | 10 MG |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Packaging as described in the monograph | Syrup: Supplied in 240 mL bottles. Solution for Infusion: Supplied as 20 mL single-use amber vial. Box of 5 vials. |
| Storage | The diluted solution should be administered within 8 hours if stored at 25ºC (77ºF) or 24 hours if refrigerated at 2º to 8ºC |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Cold chain. This product is stored refrigerated. Nexara ships it on a validated cold chain with temperature monitoring; a delivery address that cannot receive and store it at 2–8 °C on arrival must be flagged before the order is placed.
What can be used instead?
Other Canadian products sharing ATC code J05AF01 ZIDOVUDINE. 3 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-ZIDOVUDINE | 100 MG | CAPSULE | APOTEX INC | MARKETED | DIN 01946323 |
| RETROVIR (AZT) | 50 MG / 5 ML | SYRUP | VIIV HEALTHCARE ULC | MARKETED | DIN 01902652 |
| NOVO-AZT CAP 100MG | 100 MG | CAPSULE | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 01953877 |
| RETROVIR (AZT) | 100 MG | CAPSULE | VIIV HEALTHCARE ULC | CANCELLED POST MARKET | DIN 01902660 |
| RETROVIR (AZT) 300MG | 300 MG | TABLET | GLAXO WELLCOME INC. | CANCELLED POST MARKET | DIN 02238699 |
| ZIDOVUDINE ORAL SOLUTION USP | 50 MG / 5 ML | SOLUTION | AUROBINDO PHARMA LIMITED (UNIT III) | APPROVED | DIN 02282186 |
Who else supplies ZIDOVUDINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ZIDOVUDINE appears in 1364 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does ZIDOVUDINE cost around the world?
ZIDOVUDINE is listed on 8 national price registers Nexara tracks, across 49 pack listings published on 7 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| South Africa | single exit price | 24 | 30 | 01 Sep 2026 |
| Morocco | PPV (public price) | 3 | 6 | 05 Sep 2026 |
| Australia | ex-manufacturer | 1 | 3 | 08 Sep 2026 |
| Greece | producer price (ex-factory) | 3 | 3 | 03 Sep 2026 |
| United Arab Emirates | public | 1 | 2 | 31 Aug 2026 |
| Saudi Arabia | public | 2 | 2 | 01 Sep 2026 |
| United States | acquisition | 2 | 2 | 03 Sep 2026 |
| Bahrain | retail (max) | 1 | 1 | 01 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.